Reposted
RRecordati@recordati
Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
8:29:11 PM · Jul 9, 2026
Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
Our wastewater treatment used advanced oxidation with UV/H2O2 for refractory organics.
The MBR system achieved COD removal of 98% with membrane flux of 15 LMH.